Physician profile
Peter J March
NPI 1528061538
$1,327.72
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2021: $228 · 2022: $216 · 2023: $669 · 2024: $52.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $363 · Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $363.00 |
| Food and Beverage | $358.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $404.66 | 2021-2023 | Itero Element 5d Plus, Invisalign First - Comprehensive, Invisalign Go |
| Acteon INC | $363.00 | 2023 | 2 F10205 Kit of 11 Rubber Joints, 1 F10121 Ang Easy Oring Kit, 2 F10207 Supra Probe 0.5 Diameter |
| Ultradent Products INC | $239.80 | 2021-2024 | |
| Straumann USA LLC | $150.00 | 2019 | |
| Dentsply Sirona INC | $85.64 | 2021-2024 | Promark |
| Patterson Companies, INC. | $30.00 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $14.81 | 2023 | |
| 3m Company | $13.90 | 2022 | |
| Elevate Oral Care | $13.85 | 2024 | Advantage Arrest, Just Right 5000, Fluorimax 5000 |
| Implant Direct Sybron International LLC | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter March listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.